share_log

Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $220

Benzinga ·  Aug 12 08:29

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $200 to $220.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment